Patent details
EP3743072 Title: PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE DELIVERY OF BUPRENORPHINE
Basic Information
- Publication number:
- EP3743072
- PCT Application Number:
- US2019014422
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197410525
- PCT Publication Number:
- WO2019144079
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE DELIVERY OF BUPRENORPHINE
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE POUR ADMINISTRATION À LIBÉRATION PROLONGÉE DE BUPRÉNORPHINE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN FÜR DIE VERZÖGERTE FREISETZUNG VON BUPRENORPHIN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 25/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 31/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 25/10/2023
- Unitary Effect Registration Date:
- 31/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 21/01/2019
- Grant date:
- 25/10/2023
- EP Publication Date:
- 02/12/2020
- PCT Publication Date:
- 25/07/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/10/2023
- EP B1 Publication Date:
- 25/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/01/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/10/2023
- Name:
- Foresee Pharmaceuticals Co., Ltd.
- Address:
- 9F-2., No.19-3, Sanchong Rd Nangang Dist., Taipei City 115, Taiwan (R.O.C.), Taiwan (TW)
Inventor
1
- Name:
- LEE, Chen-Chang
- Address:
- Taiwan (TW)
2
- Name:
- LI, Yuhua
- Address:
- United States (US)
3
- Name:
- LIN, Chih-Ying
- Address:
- Taiwan (TW)
4
- Name:
- YANG, Chia-Ying
- Address:
- Taiwan (TW)
5
- Name:
- LI, MingHsin
- Address:
- Taiwan (TW)
Priority
- Priority Number:
- 201862620317 P
- Priority Date:
- 22/01/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/485; A61K 9/00; A61P 25/04; A61P 25/36; A61K 47/12; A61K 47/44; A61K 47/10;
Publication
European Patent Bulletin
1
- Issue number:
- 202343
- Publication date:
- 25/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202348
- Publication date:
- 29/11/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202348
- Publication date:
- 29/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|